Skip to main content

Table 1 Demographic profiles and hemodynamic data between 2 groups

From: RETRACTED ARTICLE: Dose selection of central or peripheral administration of sufentanil affect opioid induced cough?: a prospective, randomized, controlled trial

 

Group CV (n = 51)

Group PV (n = 51)

P value

Age (years)

50.0 ± 11.1

52.8 ± 9.7

0.18

Height(cm)

165.0 ± 7.5

164.9 ± 8.6

0.94

Weight (kg)

63.2 ± 9.4

64.3 ± 10.2

0.55

BMI

23.1 ± 2.4

23.6 ± 3.0

0.36

ASA (I/II)

38/13

35/16

0.66

Sex (M/F)

28/23

28/23

1.00

SBP T0

143.51 ± 12.7

144.2 ± 16.2

0.81

DBP T0

77.2 ± 7.3

76.7 ± 8.3

0.72

HR T0

75.8 ± 9.9

77.2 ± 13.1

0.54

SBP T1

125.3 ± 16.1

125.1 ± 16.6

0.93

DBP T1

69.1 ± 8.5

69.3 ± 9.0

0.89

HR T1

76.3 ± 11.0

77.9 ± 13.2

0.50

  1. Group CV central venous group, Group PV peripheral venous group, SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, T0 time before injection of sufentanil, T1 1 min after injection of sufentanil
  2. Data represented mean ± SD or numbers. Independent t-test was used. A p value of < 0.05 was considered statistically significant
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us